Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines.
Mitsiades
Constantine S
CS
Sykoutri
Despoina
D
McMullan
Ciaran
C
Poulaki
Vassiliki
V
Mitsiades
Nicholas
N
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001549:Benzamides; D002277:Carcinoma; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D013964:Thyroid Neoplasms; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate